gene_symbol
ERBB2
hgnc_id
HGNC:3430
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
HER2-binding ADC is internalized; lysosomal cleavage releases the topoisomerase I inhibitor DXd, causing DNA damage and apoptosis; Fc also mediates ADCC and there is a bystander killing effect.
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
ADC antibody component (trastuzumab) binds HER2
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06048718
disease_id_num_tar_ref
4485
drug_id_num_tar_ref
12114